Lauxera Capital Partners invests in GenePlanet in private funding round

Reuters2026/07/30 06:47

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Lauxera Capital Partners invested in GenePlanet in a private financing to fund global expansion in advanced diagnostics and genetic testing.
GenePlanet is a European genomics and laboratory platform providing genetic testing and next-generation sequencing services worldwide.
Funding targets Western Europe and the U.S., including regulatory and reimbursement work, with product expansion into oncology and rare-disease panels.
BlackPeak Capital partially exited its 2023 investment, retaining a meaningful stake as GenePlanet targets a liquidity event in three to five years.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lauxera Capital Partners SAS published the original content used to generate this news brief on July 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Lauxera Capital Partners invests in GenePlanet in private funding round

You may also like

Crypto prices